In-house roundup: Pay for delay opposed by all; AI spurs pharma IP refocus; energy digitalisation pushes patent overhaul

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

In-house roundup: Pay for delay opposed by all; AI spurs pharma IP refocus; energy digitalisation pushes patent overhaul

Drugs

Managing IP rounds up the latest news and analysis from patent-focused businesses



Money

Seminal pay for delay law opposed by pharma companies

Generics and innovator companies say they don’t like the new and ‘badly-worded’ legislation introduced by California that bans drug settlements and could actually raise drug prices. Read more... 

AI alliances will push pharma refocus on patent bundles and licensing

Pharma companies say AI’s potential to make R&D models more efficient and less expensive will drive the development of therapeutics that require different IP strategies. Read more... 

Energy digitalisation spurs industry IP overhaul

SBM Offshore and IFP Energies explain how the energy sector has embraced digital technologies such as AI to drive efficiencies – and how that move is creating data rights and eligibility challenges. Read more... 




more from across site and SHARED ros bottom lb

More from across our site

The IP services provider is targeting further expansion as cost and efficiency pressures push law firms and in-house teams to rethink how they manage global portfolios
Two experienced UPC practitioners join the UK IP boutique’s growing German operation, with further recruitment planned as the firm expands in Europe
The Australian IP firm is taking on bigger rivals in Southeast Asia, betting that agility and transparent pricing can help it stand out
The firm has brought in former Weil IP leaders Doug Lumish and Jeff Homrig as it looks to deepen its patent, trade secrets and ITC bench
Bird & Bird helps GSK score a major injunction as the battle to become the UPC’s busiest division tightens, and overall filings reach a new monthly high
CEO Annette Bach explains how the Danish IP consultancy plans to build on its 65% profit growth while keeping external investment off the table for now
Belgian attorneys have revived fax systems to protect clients’ filing rights, while uncertainty over exposed patent data has left firms struggling to answer questions about the breach
In his first interview since leaving Weil Gotshal & Manges, Chris Henry explains why he returned to Latham and how he plans to bolster its tech disputes offering
As GTA VI underlines the extraordinary value of gaming franchises, lawyers at Clifford Chance say investors need to know the IP behind their next deal can deliver the growth they are paying for
As ‘big law’ invests in IP litigation, trial firms are emerging as a valuable source of seasoned courtroom talent
Gift this article